8. Referenze
bibliografiche
REFERENZE BIBLIOGRAFICHE
1. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 93:13742-13747.
2. Aukerman MJ, Sakai H. 2003. Regulation of flowering time and floral organ identity by a MicroRNA and its APETALA2-like target genes. Plant Cell 15:2730-2741.
3. Bartel B, Bartel DP. 2003. MicroRNAs: at the root of plant development? Plant Physiol 132:709-717.
4. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
5. Bartel DP, Chen CZ. 2004. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5:396-400.
6. Baskerville S, Bartel DP. 2005. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241-247.
7. Ben-Porath I, Weinberg RA. 2004. When cells get stressed: an integrative view of cellular senescence. J Clin Invest 113:8-13.
8. Ben-Porath I, Weinberg RA. 2005. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37:961-976.
9. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-366.
10. Blasco MA, Gasser SM, Lingner J. 1999. Telomeres and telomerase. Genes Dev 13:2353-2359.
11. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. 2003. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113:25-36.
12. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M,
Rattan S, Bullrich F, Negrini M, Croce CM. 2004. Human microRNA genes are
frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101:2999-3004.
13. Campisi J. 2000. Cancer, aging and cellular senescence. In Vivo 14:183-188.
14. Campisi J. 2005. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120:513-522.
15. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033.
16. Chen CZ, Li L, Lodish HF, Bartel DP. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86.
17. Chen X. 2004. A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development. Science 303:2022-2025.
18. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE,
Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2.
Proc Natl Acad Sci U S A 102:13944-13949.
19. De Petro G, Copeta A, Barlati S. 1994. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res 213:286-294.
20. Elbashir SM, Lendeckel W, Tuschl T. 2001. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15:188-200.
21. Emery JF, Floyd SK, Alvarez J, Eshed Y, Hawker NP, Izhaki A, Baum SF, Bowman
JL. 2003. Radial patterning of Arabidopsis shoots by class III HD-ZIP and KANADI genes.
Curr Biol 13:1768-1774.
22. Gil J, Peters G. 2006. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7:667-677.
23. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D,
Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R. 2007. Micro-RNA profiling in
kidney and bladder cancers. Urol Oncol 25:387-392.
24. Griffiths-Jones S. 2004. The microRNA Registry. Nucleic Acids Res 32:D109-111.
25. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. 2006. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140-144. 26. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2008. miRBase: tools for
microRNA genomics. Nucleic Acids Res 36:D154-158.
27. Hammond SM. 2005. Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett 579:5822-5829.
28. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. 1996. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16:859-867.
29. Hayashi K, Chuva de Sousa Lopes SM, Kaneda M, Tang F, Hajkova P, Lao K,
O'Carroll D, Das PP, Tarakhovsky A, Miska EA, Surani MA. 2008. MicroRNA
Biogenesis Is Required for Mouse Primordial Germ Cell Development and Spermatogenesis. PLoS ONE 3:e1738.
30. Hayflick L, Moorhead PS. 1961. The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621.
31. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J,
Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ. 2007.
A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134. 32. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S,
Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. 2005. A microRNA
polycistron as a potential human oncogene. Nature 435:828-833.
33. Houbaviy HB, Murray MF, Sharp PA. 2003. Embryonic stem cell-specific MicroRNAs. Dev Cell 5:351-358.
34. Huang EY, Wu H, Island ER, Chong SS, Warburton D, Anderson KD, Tuan TL. 2002. Differential expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in early and late gestational mouse skin and skin wounds. Wound Repair Regen 10:387-396.
35. Hwang HW, Mendell JT. 2006. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94:776-780.
36. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali
M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. 2005. MicroRNA gene
expression deregulation in human breast cancer. Cancer Res 65:7065-7070.
37. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E,
Reinert KL, Brown D, Slack FJ. 2005. RAS is regulated by the let-7 microRNA family.
Cell 120:635-647.
38. Johnson SM, Lin SY, Slack FJ. 2003. The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter. Dev Biol 259:364-379.
39. Jovanovic M, Hengartner MO. 2006. miRNAs and apoptosis: RNAs to die for. Oncogene 25:6176-6187.
40. Kane CD, Greenhalgh DG. 2000. Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Repair Regen 8:45-58.
41. Kolle G, Georgas K, Holmes GP, Little MH, Yamada T. 2000. CRIM1, a novel gene encoding a cysteine-rich repeat protein, is developmentally regulated and implicated in vertebrate CNS development and organogenesis. Mech Dev 90:181-193.
42. Kortlever RM, Higgins PJ, Bernards R. 2006. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 8:877-884.
43. Lee R, Feinbaum R, Ambros V. 2004. A short history of a short RNA. Cell 116:S89-92, 81 p following S96.
44. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854.
45. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. 2002. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21:4663-4670.
46. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115:787-798.
47. Lim LP, Lau NC, Weinstein EG, Abdelhakim A, Yekta S, Rhoades MW, Burge CB,
Bartel DP. 2003. The microRNAs of Caenorhabditis elegans. Genes Dev 17:991-1008.
48. Lloyd AC. 2002. Limits to lifespan. Nat Cell Biol 4:E25-27.
49. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell JE. c1999. Molecular Cell Biology.
50. Lowe SW, Sherr CJ. 2003. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 13:77-83.
51. Martens JW, Sieuwerts AM, Bolt-deVries J, Bosma PT, Swiggers SJ, Klijn JG,
Foekens JA. 2003. Aging of stromal-derived human breast fibroblasts might contribute to
breast cancer progression. Thromb Haemost 89:393-404.
52. McManus MT. 2003. MicroRNAs and cancer. Semin Cancer Biol 13:253-258.
53. Mu XC, Higgins PJ. 1995. Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts. J Cell Physiol 165:647-657.
54. Murphree AL, Benedict WF. 1984. Retinoblastoma: clues to human oncogenesis. Science 223:1028-1033.
55. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839-843.
56. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y, Seto M. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64:3087-3095.
57. Palatnik JF, Allen E, Wu X, Schommer C, Schwab R, Carrington JC, Weigel D. 2003. Control of leaf morphogenesis by microRNAs. Nature 425:257-263.
58. Palmero I, McConnell B, Parry D, Brookes S, Hara E, Bates S, Jat P, Peters G. 1997. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene 15:495-503.
59. Pantoja C, Serrano M. 1999. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18:4974-4982.
60. Pasquinelli AE, Hunter S, Bracht J. 2005. MicroRNAs: a developing story. Curr Opin Genet Dev 15:200-205.
61. Rainer J, Sanchez-Cabo F, Stocker G, Sturn A, Trajanoski Z. 2006. CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res 34:W498-503.
62. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. 2004. Identification of mammalian microRNA host genes and transcription units. Genome Res 14:1902-1910. 63. Ruvkun G, Wightman B, Ha I. 2004. The 20 years it took to recognize the importance of
tiny RNAs. Cell 116:S93-96, 92 p following S96.
64. Serrano M, Blasco MA. 2001. Putting the stress on senescence. Curr Opin Cell Biol 13:748-753.
65. Sevignani C, Calin GA, Siracusa LD, Croce CM. 2006. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 17:189-202.
66. Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA. 2004. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 23:379-385.
67. Sherr CJ. 2006. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6:663-673. 68. Sherr CJ, DePinho RA. 2000. Cellular senescence: mitotic clock or culture shock? Cell
102:407-410.
69. Sherr CJ, McCormick F. 2002. The RB and p53 pathways in cancer. Cancer Cell 2:103-112.
70. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY, Cha KY, Chung HM, Yoon HS,
Moon SY, Kim VN, Kim KS. 2004. Human embryonic stem cells express a unique set of
microRNAs. Dev Biol 270:488-498.
71. Takahashi A. 2007. A novel mechanism of irreversible cell cycle arrest in cellular senescence. J Oral Biosci 49:47-53.
72. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI,
Ide T, Saya H, Hara E. 2006. Mitogenic signalling and the p16INK4a-Rb pathway
73. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T,
Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. 2004. Reduced expression
of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753-3756.
74. Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, Kikkawa U,
Nishizuka Y. 1992. Cell division arrest induced by phorbol ester in CHO cells
overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci U S A 89:10159-10163.
75. Wienholds E, Plasterk RH. 2005. MicroRNA function in animal development. FEBS Lett 579:5911-5922.
76. Wilkinson L, Kolle G, Wen D, Piper M, Scott J, Little M. 2003. CRIM1 regulates the rate of processing and delivery of bone morphogenetic proteins to the cell surface. J Biol Chem 278:34181-34188.
77. Xu P, Vernooy SY, Guo M, Hay BA. 2003. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13:790-795.
78. Zamore PD, Tuschl T, Sharp PA, Bartel DP. 2000. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25-33. 79. Zindy F, Quelle DE, Roussel MF, Sherr CJ. 1997. Expression of the p16INK4a tumor
suppressor versus other INK4 family members during mouse development and aging. Oncogene 15:203-211.
